An observational study in Cardiac Arrest (CA), Cardiogenic Shock and Mechanical Ventilation, sponsored by Laval University. Recruiting at 1 site in Canada. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by Laval University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 65 studies in Heart Arrest with a site in Canada — 10 open to participants now, 13 under way, 1 of them phase 3. Heart Arrest · Canada.
Among the 65 studies in Heart Arrest with a site in Canada, this one is the 16th largest by planned enrollment of the 19 observational ones that give a count, is one of 3 that started in 2026, is one of 19 observational ones, reaches primary completion later than 5 of the 12 other live ones, and was the 62nd registered.
927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.
Browse Heart Arrest studies →10 of the 65 studies in Heart Arrest with a site in Canada are open now. Recruiting first, the newest first:
Columbia University · Sites in Canada, United States, Brazil and 2 more countries
Ages 18+
University of Calgary · Sites in Canada
Johns Hopkins University · Sites in Canada, United States
Ages 18+ · Healthy volunteers
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Sites in Canada
Ages 1 days–17 yrs
KidSIM Simulation Program · Sites in Canada, United States
Ages 18–60 · Healthy volunteers
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
65 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 5 · Phase 3 5 · Phase 4 1
First in 1992; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is below the median of 200 across 376 observational studies indexed under Heart Arrest.
Median enrollment 246 across the 46 interventional studies, 793 across the 19 observational. Of the 44 that completed or were terminated, 20 (45%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 65 have an industry lead sponsor. The 10 most frequent:
Laval University is the lead sponsor of 380 studies on the registry; 67 are open to participants now.
Laval University has 1 study filed under Heart Arrest — fewer than ten, so there is no comparison to draw.
2 of the studies in Heart Arrest with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07829887University of CalgaryCerebral Oximetry in Management of Post Cardiac Arrest | 2027-02 |
| NCT07484828Laval UniversityEvaluation of Acid-base Disorders and Ventilation Settings in Cardiogenic Shock and Post-cardiac Arrest Patients: Comparison With VentilO Algorithm | 2027-06 |
Add all 2 to your calendar (.ics) → With an account.
Among the 65 studies in Heart Arrest with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to better understand how mechanical ventilation settings affect patients admitted to the coronary care unit after cardiac arrest or with cardiogenic shock. These patients often require mechanical ventilation, but current guidelines provide limited evidence on the best approach. Improper ventilation settings can lead to acid-base imbalances, such as respiratory acidosis or alkalosis, which may worsen patient outcomes.
The retrospective analysis will include 100 adult patients (50 post-cardiac arrest and 50 with cardiogenic shock) who were mechanically ventilated upon admission. The study has two main objectives:
Determine how often acid-base disorders occur in these patients and describe their characteristics.
Compare the initial ventilator settings chosen by clinicians with those suggested by VentilO, a decision-support algorithm.
The investigators will evaluate the potential effect of the VentilO recommendations on the first arterial (or capillary) blood gases compared to the real settings.
This information will help refine the algorithm and guide future research on improving ventilation strategies for critically ill cardiac patients.
Participation does not involve any intervention, as the study uses existing medical records.
post cardiac arrest or cardiogenic shock
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
post cardiac arrest or cardiogenic shock
- Bood gases result availability up to 4 hours after coronary unit admission
Exclusion Criteria:
Other: Initiation of mechanical ventilation
Other: Initiation of mechanical ventilation
Blood gases evaluation after initiation of mechanical ventilation
Acid-base disorder (respiratory acidosis)
Presence of respiratory acisosis define by pH\< 7.35 and PaCO2 \> 45 mmHg
Time frame: Up to 4 hours after admission to the coronary care unit - First blood gas sample
Acid-base disorder (respiratory alcalosis)
Presence of respiratory alcalosis define by by pH\>7.45 and PaCO2 \< 35 mmHg
Time frame: Up to 4 hours after admission to the coronary care unit - First blood gas sample
Ventilator setting (Respiratory rate)
Respiratory rate set by the doctor, these setting will be compared to the suggestion of the algorithm
Time frame: Up to 4 hour after coronary unit admission - At the last ventilator setting before blood gas sample
Ventilator setting (Tidal volume)
Tidal volume set by the doctor, these setting will be compared to the suggestion of the algorithm
Time frame: Up to 4 hour after coronary unit admission - At the last ventilator setting before blood gas sample
Acid-base disorder (metabolic acidosis)
Presence of metabolic acidosis define by HCO3 \< 20 mmol/L
Time frame: Up to 4 hours after admission to the coronary care unit - First blood gas sample
Acid-base disorder (metabolic alcalosis)
Presence of metabolic acidosis define by HCO3 \> 28 mmol/L
Time frame: Up to 4 hours after admission to the coronary care unit - First blood gas sample
Optimal acid-base result
Presence of optimal pH (7.35-7.45) with optimal PCO2 (35-45 mmHg)
Time frame: Up to 4 hours after admission to the coronary care unit - First blood gas sample
Mechanical ventilation duration
Time spent with invasive mechanical ventilation aftercoronary unit admission and hospital discharge
Time frame: Up to 90 days
Vasopressor duration
Duration of vasopressor or inotrop administration
Time frame: Day 28
Hospital length of stay
Coronary unit admission through hospital discharge
Time frame: Up to 90 days
Mortality
Mortality at coronary unit
Time frame: Day 28
Acute renal failure
Rate of acute renal failure during coronary unit length of stay. Renal failure will be defined according to the usual criteria, i.e., an increase of \>27 mmol/L creatinine in 48 hours or 1.5x over the baseline
Time frame: Up to 90 days. Coronary unit stay - admission through discharge or until death if occured
Plan to share: No
No publications or documents are linked to this record.
Started Jun 2026 (actual). Primary completion is estimated for Jun 2027, 12 months after the start.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: start May 2026 → Jun 2026, primary completion Sep 2026 → Jun 2027 and completion Dec 2026 → Dec 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.